New Jersey Woman Turns Her Own CBD Anxiety Treatment into Million-Dollar Business – LPC
This story about a CBD anxiety treatment is a familiar one with a new twist. Alexis Rosenbaum suffered from severe anxiety and tried cannabis to relieve her symptoms. However, she didn’t like the side effects.
“I saw immense changes in my life and stress levels, but, without being able to microdose, I sometimes became paranoid,” Rosenbaum said. “So, I hunted for something else to use.”
That’s when she tried cannabidiol as a CBD anxiety treatment.
“It helped me catch my breath, feel more in control and slow down,” Rosenbaum said.
She had to essentially self-medicate since her CBD anxiety treatment is not widely accepted in the medical community. CBD remedies are gaining acceptance, but the problem is that there isn’t hard proof that they work. Without that proof – along with documented side effects – doctors won’t likely jump on the CBD bandwagon.
That’s changing though. Since cannabis was legalized in Canada in 2018, it has opened up more research. The US legalized hemp in December 2018, allowing companies like Rosenbaum’s to start bringing CBD anxiety treatments and other CBD medications to market.
Quality Control Important – LPC
Another reason why doctors – and the US Food and Drug administration (FDA) – are hesitant to recommend CBD anxiety treatment and other CBD medications is quality control. One study found that two-thirds of CBD remedies didn’t have the amount of CBD they advertised.
Rosenbaum found that she couldn’t guarantee her own supply either.
“I still couldn’t identify where the hemp was being grown or how many people touched the product before it reached me,” she said. “That’s why having a direct connection with our farm is really important. Our product is handled by the same people all the way from seed to bottle, so there isn’t a lot of room for error.”
She partnered with a farm in Eugene, Oregon, tested their products, and ultimately launched her own brand: Rosebud. Already she has reached a million dollars in sales of her CBD anxiety treatment. As research – and acceptance – continues to grow, her business likely will too.
This editorial content from the LPC News Editor is meant to provide analysis, insight, and perspective on current news articles. To read the source article this LPC commentary is based upon, please click on the link below.